Use of Reverse Phase Protein Arrays to Identify Biomarkers of Response to PI3K/mTOR Inhibitors in Ovarian Cancer Models

被引：0
|
作者：
Tashkandi, G. [1 ]
Mullen, P. [2 ]
Goltsov, A. [3 ]
Bown, J. L. [3 ]
Harrison, D. J. [2 ]
Langdon, S. P. [1 ]
机构：
[1] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland
[2] Univ St Andrews, Sch Med, St Andrews, Fife, Scotland
[3] Univ Abertay, CRISP, Dundee, Scotland
来源：
JOURNAL OF PATHOLOGY | 2013年 / 231卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [1] PI3K/AKT/mTOR Inhibitors In Ovarian Cancer
    Mazzoletti, M.
    Broggini, M.
    CURRENT MEDICINAL CHEMISTRY, 2010, 17 (36) : 4433 - 4447
  • [2] Biomarkers for predicting response to PI3K inhibitors
    Cantley, Lewis C.
    CANCER RESEARCH, 2011, 71
  • [3] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [4] PI3K/Akt/mTOR inhibitors in breast cancer
    Lee, Joycelyn J. X.
    Loh, Kiley
    Yap, Yoon-Sim
    CANCER BIOLOGY & MEDICINE, 2015, 12 (04) : 342 - 354
  • [5] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, (04) : 342 - 354
  • [6] PI3K/Akt/mTOR inhibitors in breast cancer
    Joycelyn JX Lee
    Kiley Loh
    Yoon-Sim Yap
    Cancer Biology & Medicine, 2015, 12 (04) : 342 - 354
  • [7] Selective PI3K and dual PI3K/mTOR inhibitors enhance the efficacy of endocrine therapies in breast cancer models
    Friedman, L.
    Ross, L. B.
    Wallin, J.
    Guan, J.
    Prior, W. W.
    Wu, E.
    Nannini, M.
    Sampath, D.
    CANCER RESEARCH, 2012, 72
  • [8] Understanding resistance mechanisms to PI3K/mTOR inhibitors in ovarian cancer model systems
    Tashkandi, Ghassan
    Goltsov, Alexey
    Mullen, Peter
    Bown, Jim
    Harrison, David
    Langdon, Simon
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [9] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [10] Defining biomarkers to predict sensitivity to PI3K/Akt/mTOR pathway inhibitors in breast cancer
    Gonzalez-Angulo, A. M.
    Blumenschein, G. R., Jr.
    CANCER TREATMENT REVIEWS, 2013, 39 (04) : 313 - 320
12345